Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males. Despite its prevalence, this

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread to there. Learn about those types.

Archie Emanuel, Jr., a Vietnam-era veteran, remembered the day he received his diagnosis. “I had all the blood work and the urologist found out I had cancer,” he said. “It hit me so hard. Cancer! Here I just found my soul mate and I just got engaged.

Prostate cancer has now become the most common cancer in the UK with more than 50,000 cases per year and is more common than breast cancer. This cancer now affects one and eight men and causes 12,000 deaths per year in the UK.

Learn the vital signs of prostate cancer that you shouldn't ignore, from urinary changes to pelvic discomfort. Early detection could be your key to successful treatment.

Researchers have discovered a new approach to prostate cancer treatment by combining immunotherapy with PIM1 kinase inhibition.

Researchers at Keck Medicine of USC are part of a national, multisite clinical trial to evaluate a minimally invasive water vapor system that uses steam to treat prostate cancer.Vanquish Water Vapor Ablation System (Francis Medical) uses small,

MEN are not the best at taking care of themselves. We tend to ignore pains hoping they’ll go away rather than heading to the doctor’s surgery.

After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I committed myself to being there for my cousin. Patients with intermediate-risk prostate cancer had a 15-year prostate cancer–specific ...

Investigators assessed lifestyle and dietary patterns of more than 2000 men with nonmetastatic prostate cancer using three prostate cancer behavior scores and 13 dietary indices.

A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined with a synergistic treatment approach. The paper was published in the journal Cancer Immunology Research.

Errol McKellar takes over Afternoon Edition to talk about Prostate Cancer & men's health.